Business
Perimeter Medical Imaging AI to Host Investor Webcast on June 25
Perimeter Medical Imaging AI to Host Investor Webcast on June 25 Canada NewsWire ...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n \n \n \n Perimeter Medical Imaging AI to Host Investor Webcast on June 25\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n and\n \n DALLAS\n \n \n ,\n \n \n June 19, 2024\n \n \n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (\"Perimeter\" or the \"Company\") – a commercial-stage medical technology company, today announced that it will host a webcast investor presentation on\n \n Tuesday, June 25, 2024\n \n at\n \n 2:00 PM ET\n \n .\n \n \n During the webcast,\n \n Adrian Mendes\n \n , CEO,\n \n Andrew Berkeley\n \n , CIO and\n \n Sara Brien\n \n , CFO, will conduct a presentation that will cover key areas of Perimeter's business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal. To listen to the webcast or to ask questions during the live event, please pre-register at the following link:\n \n \n https://us02web.zoom.us/webinar/register/WN_u8RVMf9_Qaik3JmCOKKTPw\n \n \n \n An archived version of the webcast and presentation will be available on the Company's website:\n \n https://ir.perimetermed.com/news-events/ir-calendar\n \n \n \n \n About Perimeter Medical Imaging AI, Inc.\n \n \n Based in\n \n Toronto, Canada\n \n and\n \n Dallas, Texas\n \n ,\n \n \n Perimeter Medical Imaging AI\n \n \n (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to\n \n US$7.4 million\n \n awarded by the Cancer Prevention and ...